BRUKER CORPORATION Other Revenue, Net (Deprecated 2018-01-31)
BRUKER CORPORATION (BRKR) reported Other Revenue, Net (Deprecated 2018-01-31) of $8.20 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-16.
Discontinued › Income Statement › Other Income
us-gaap:OtherSalesRevenueNet · last filed 2018-03-16
- BRUKER CORPORATION other revenue, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $2.40M, a 14.29% decline year-over-year.
- BRUKER CORPORATION other revenue, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $1.20M, a 64.71% decline year-over-year.
- BRUKER CORPORATION other revenue, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $1.90M, a 26.92% decline year-over-year.
- BRUKER CORPORATION other revenue, net (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $2.70M, a 12.50% increase year-over-year.
- BRUKER CORPORATION other revenue, net (deprecated 2018-01-31) for fiscal 2017 was $8.20M, a 26.79% decline from fiscal 2016.
- BRUKER CORPORATION other revenue, net (deprecated 2018-01-31) for fiscal 2016 was $11.20M, a 55.56% increase from fiscal 2015.
- BRUKER CORPORATION other revenue, net (deprecated 2018-01-31) for fiscal 2015 was $7.20M, a 38.46% increase from fiscal 2014.
- BRUKER CORPORATION other revenue, net (deprecated 2018-01-31) for fiscal 2014 was $5.20M, a 40.23% decline from fiscal 2013.
| Period end | Other Revenue, Net (Deprecated 2018-01-31) 3 month | Other Revenue, Net (Deprecated 2018-01-31) 6 month | Other Revenue, Net (Deprecated 2018-01-31) 9 month | Other Revenue, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2017-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $3.60M derived: sum of 2 quarters · filed 2018-03-16 | $5.50M derived: sum of 3 quarters · filed 2018-03-16 | $8.20M 10-K · filed 2018-03-16 |
| 2017-09-30 | $1.20M 10-Q · filed 2017-11-09 | $3.10M derived: sum of 2 quarters · filed 2017-11-09 | $5.80M 10-Q · filed 2017-11-09 | $8.60M derived: sum of 4 quarters · filed 2018-03-16 |
| 2017-06-30 | $1.90M 10-Q · filed 2017-08-09 | $4.60M 10-Q · filed 2017-08-09 | $7.40M derived: sum of 3 quarters · filed 2018-03-16 | $10.80M derived: sum of 4 quarters · filed 2018-03-16 |
| 2017-03-31 | $2.70M 10-Q · filed 2017-05-10 | $5.50M derived: sum of 2 quarters · filed 2018-03-16 | $8.90M derived: sum of 3 quarters · filed 2018-03-16 | $11.50M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-12-31 | $2.80M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $6.20M derived: sum of 2 quarters · filed 2018-03-16 | $8.80M derived: sum of 3 quarters · filed 2018-03-16 | $11.20M 10-K · filed 2018-03-16 |
| 2016-09-30 | $3.40M 10-Q · filed 2017-11-09 | $6.00M derived: sum of 2 quarters · filed 2017-11-09 | $8.40M 10-Q · filed 2017-11-09 | $9.90M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-06-30 | $2.60M 10-Q · filed 2017-08-09 | $5.00M 10-Q · filed 2017-08-09 | $6.50M derived: sum of 3 quarters · filed 2018-03-16 | $9.20M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-03-31 | $2.40M 10-Q · filed 2017-05-10 | $3.90M derived: sum of 2 quarters · filed 2018-03-16 | $6.60M derived: sum of 3 quarters · filed 2018-03-16 | $8.20M derived: sum of 4 quarters · filed 2018-03-16 |
| 2015-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $4.20M derived: sum of 2 quarters · filed 2018-03-16 | $5.80M derived: sum of 3 quarters · filed 2018-03-16 | $7.20M 10-K · filed 2018-03-16 |
| 2015-09-30 | $2.70M 10-Q · filed 2016-11-09 | $4.30M derived: sum of 2 quarters · filed 2016-11-09 | $5.70M 10-Q · filed 2016-11-09 | $7.90M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $1.60M 10-Q · filed 2016-08-05 | $3.00M 10-Q · filed 2016-08-05 | $5.20M derived: sum of 3 quarters · filed 2017-03-01 | $6.80M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $1.40M 10-Q · filed 2016-05-06 | $3.60M derived: sum of 2 quarters · filed 2017-03-01 | $5.20M derived: sum of 3 quarters · filed 2017-03-01 | $6.00M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $3.80M derived: sum of 2 quarters · filed 2017-03-01 | $4.60M derived: sum of 3 quarters · filed 2017-03-01 | $5.20M 10-K · filed 2017-03-01 |
| 2014-09-30 | $1.60M 10-Q · filed 2015-11-06 | $2.40M derived: sum of 2 quarters · filed 2015-11-06 | $3.00M 10-Q · filed 2015-11-06 | $3.60M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $800.00K 10-Q · filed 2015-08-07 | $1.40M 10-Q · filed 2015-08-07 | $2.00M derived: sum of 3 quarters · filed 2016-02-29 | $2.90M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $600.00K 10-Q · filed 2015-05-08 | $1.20M derived: sum of 2 quarters · filed 2016-02-29 | $2.10M derived: sum of 3 quarters · filed 2016-02-29 | $8.70M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $1.50M derived: sum of 2 quarters · filed 2016-02-29 | $8.10M derived: sum of 3 quarters · filed 2016-02-29 | $8.70M 10-K · filed 2016-02-29 |
| 2013-09-30 | $900.00K 10-Q · filed 2014-11-07 | $7.50M derived: sum of 2 quarters · filed 2014-11-07 | $8.10M 10-Q · filed 2014-11-07 | $10.10M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | $6.60M 10-Q · filed 2014-08-08 | $7.20M 10-Q · filed 2014-08-08 | $9.20M derived: sum of 3 quarters · filed 2015-02-27 | $27.50M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | $600.00K 10-Q · filed 2014-05-09 | $2.60M derived: sum of 2 quarters · filed 2015-02-27 | $20.90M derived: sum of 3 quarters · filed 2015-02-27 | $23.80M derived: sum of 4 quarters · filed 2015-02-27 |
| 2012-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $20.30M derived: sum of 2 quarters · filed 2015-02-27 | $23.20M derived: sum of 3 quarters · filed 2015-02-27 | $24.90M 10-K · filed 2015-02-27 |
| 2012-09-30 | $18.30M 10-Q · filed 2013-11-08 | $21.20M derived: sum of 2 quarters · filed 2013-11-08 | $22.90M 10-Q · filed 2013-11-08 | $28.50M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | $2.90M 10-Q · filed 2013-08-08 | $4.60M 10-Q · filed 2013-08-08 | $10.20M derived: sum of 3 quarters · filed 2014-02-27 | $12.30M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | $1.70M 10-Q · filed 2013-05-09 | $7.30M derived: sum of 2 quarters · filed 2014-02-27 | $9.40M derived: sum of 3 quarters · filed 2014-02-27 | $11.70M derived: sum of 4 quarters · filed 2014-02-27 |
| 2011-12-31 | $5.60M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $7.70M derived: sum of 2 quarters · filed 2014-02-27 | $10.00M derived: sum of 3 quarters · filed 2014-02-27 | $11.30M 10-K · filed 2014-02-27 |
| 2011-09-30 | $2.10M 10-Q · filed 2012-11-08 | $4.40M derived: sum of 2 quarters · filed 2012-11-08 | $5.70M 10-Q · filed 2012-11-08 | $9.10M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-06-30 | $2.30M 10-Q · filed 2012-08-09 | $3.60M 10-Q · filed 2012-08-09 | $7.00M derived: sum of 3 quarters · filed 2013-02-28 | $8.40M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-03-31 | $1.30M 10-Q · filed 2012-05-09 | $4.70M derived: sum of 2 quarters · filed 2013-02-28 | $6.10M derived: sum of 3 quarters · filed 2013-02-28 | $7.50M derived: sum of 4 quarters · filed 2013-02-28 |
| 2010-12-31 | $3.40M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $4.80M derived: sum of 2 quarters · filed 2013-02-28 | $6.20M derived: sum of 3 quarters · filed 2013-02-28 | $8.40M 10-K · filed 2013-02-28 |
| 2010-09-30 | $1.40M 10-Q · filed 2011-11-09 | $2.80M derived: sum of 2 quarters · filed 2011-11-09 | $5.00M 10-Q · filed 2011-11-09 | |
| 2010-06-30 | $1.40M 10-Q · filed 2011-08-09 | $3.60M 10-Q · filed 2011-08-09 | ||
| 2010-03-31 | $2.20M 10-Q · filed 2011-05-09 | |||
| 2009-12-31 | $6.80M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |